Komen for the Cure’s Biggest Mistake Is About Science, Not Politics

Title: Komen for the Cure’s Biggest Mistake Is About Science, Not Politics

Author: Christie Aschwanden

Publication:  Discover Magazine (This post originally ran on the blog Last Word on Nothing.)

Date: February 10, 2012

The Planned Parenthood debacle brought renewed attention to other controversies about Komen from recent years—like its “lawsuits for the cure” program that spent nearly $1 million suing groups like “cupcakes for the cure” and “kites for the cure” over their daring attempts to use the now-trademarked phrase “for the cure.” Critics also pointed to Komen’s relentless marketing of pink ribbon-themed products, including a Komen-branded perfume alleged to contain carcinogens, and pink buckets of fried chicken, a campaign that led one rival breast cancer advocacy group to ask, “what the cluck?”…

But these problems are minuscule compared to Komen’s biggest failing—its near outright denial of tumor biology…the notion that breast cancer is a uniformly progressive disease that starts small and only grows and spreads if you don’t stop it in time is flat out wrong. I call it breast cancer’s false narrative, and it’s a fairy tale that Komen has relentlessly perpetuated…

Komen isn’t wrong to encourage women to consider mammography. But they’re dead wrong to imply that “the key to surviving breast cancer” is “you” and the difference between a 98% survival rate and a 23% one is vigilance on the part of the victim. This message flies in the face of basic cancer biology…

Link to Full Article

Komen charity under microscope for funding, science

Title: Komen charity under microscope for funding, science

Author: Sharon Begley

Publication:  Reuters

Date: February 7, 2012

The Susan G. Komen for the Cure charity defines its mission as finding a cure for breast cancer. In recent years, however, it has cut by nearly half the proportion of fund-raising dollars it spends on grants to scientists working to understand the causes and develop effective new treatments for the disease…

Critics within the philanthropic and research communities in particular have raised questions over its scientific approach to some issues and how it spends the money it raises…

Link to Full Article